Company news
Oxford BioDynamics PLC news in 2024
Oxford BioDynamics PLC's news releases, calls and decks from 2024, newest first.
Issue of shares, Director / PDMR holdings and TVR
December 24, 2024
Shareholder Loan and Related Party Transaction
December 19, 2024
Directorate Change, Funding Update & Joint Broker
December 16, 2024
Response to Share Price Movement
December 3, 2024
Director / PDMR holdings and Total Voting Rights
October 28, 2024
Prognostic Covid Severity Test Study Published
October 25, 2024
CiRT Receives Clinical Approval from NYS CLEP
October 22, 2024
Commercial update for FY24
October 14, 2024
CIRRP Award Update
October 7, 2024
OBD pursuing EpiSwitch as companion diagnostics
July 25, 2024
Grant of Options
June 21, 2024
Half-year Report
June 18, 2024
OBD's PSE test to be used in NCI trial
June 6, 2024
OBD develops multi-cancer diagnostic test for dogs
June 4, 2024
OBD partners with Goodbody Clinic on PSE test
May 23, 2024
OBD partners with The London Clinic for PSE & CiRT
May 21, 2024
OBD and King's College London collaborate on RA
May 16, 2024
Results of GM
April 3, 2024
OBD opens UK clinical testing facility
April 3, 2024
Results of Fundraising
March 14, 2024
PrimaryBid Offer
March 13, 2024
Annual Report & Accounts
February 22, 2024